Zacks Research

HealthEquity Stock Touches 52-Week High; Offers 28% YTD Returns, Zacks Research Upgrades Stock Rating

HealthEquity Stock Touches 52-Week High; Offers 28% YTD Returns, Zacks Research Upgrades Stock Rating

Zacks Equity Research has issued an “Outperform” rating for HealthEquity, Inc.

DTE Energy Stock Price in Focus after Zacks Research Upgrade with Target at $148

DTE Energy Stock Price in Focus after Zacks Research Upgrade with Target at $148

Zacks Equity Research has upgraded DTE Energy Company (DTE) from a “Neutral” to an “Outperform” rating, reflecting its strong performance and investment potential in the utility sector.

Kimberly-Clark (KMB) Stock Price in Focus as Zacks Research Recommends "BUY" Call

Kimberly-Clark (KMB) Stock Price in Focus as Zacks Research Recommends "BUY" Call

Zacks Equity Research has issued an "Outperform" recommendation for Kimberly-Clark (KMB), with a price target of $170.00 over the next 6-12 months.

ROKU Stock Price Jumps 2% to $79; Outperform Rating by Zacks Research

ROKU Stock Price Jumps 2% to $79; Outperform Rating by Zacks Research

Zacks Equity Research has recently upgraded Roku Incorporated (ROKU) to an Outperform Ratings, with a 6-12 month price target of $90.00.

Gilead Sciences Stock Trades Flat; Neutral Rating by Zacks Research with $89 Price Target

Gilead Sciences Stock Trades Flat; Neutral Rating by Zacks Research with $89 Price Target

Gilead Sciences Inc.

Procter & Gamble Stock Price Declines Marginally; Zacks Research Maintains "Neutral" Rating

Procter & Gamble Stock Price Declines Marginally; Zacks Research Maintains "Neutral" Rating

Zacks Research has maintained a "Neutral" rating on Procter & Gamble (PG), one of the largest consumer goods companies globally.

Pages